Articles by Marc Iskowitz

Article

Dashboard discord: 5 reasons pharma reps ignore HQ guidance

Sep 09 2026

The Space Life Sciences Podcast

Oncology confidential: candid perspectives from a 28-year oncology sales veteran

Aug 10 2026

The Beghou Biopharma Review

The conference season, distilled, in this summer debrief

Jul 31 2026

The Beghou Biopharma Review

H1’s most consequential commercialization trends; 3 questions for Star Therapeutics’ Jacob Lai

Jul 27 2026

Article

Biopharma’s own AI myth-busters separate tall tale from truism

Jul 02 2026

Article

Fast 5: MFN has reset pharma launch strategy

Jun 26 2026

The Space Life Sciences Podcast

Why capital efficiency anchors biotech’s new commercial playbook

Jun 17 2026

The Space Life Sciences Podcast

Moving clinical minds: Why strong data don't always translate into clinical adoption​

May 21 2026

The Space Life Sciences Podcast

Fixing pre-launch commercial ops mistakes

Apr 30 2026

FAST 5

Obesity pill launches show Lilly, Novo plugging operational gaps

Apr 10 2026

FAST 5

Patients are reshaping the health information journey

Mar 29 2026

FAST 5

J&J’s new psoriasis pill to challenge older biologics

Mar 23 2026

FAST 5

Could an FDA official’s exit spell regulatory relief for biotech?

Mar 20 2026

The Beghou Biopharma Review

Rep, regulatory shifts quicken pharma’s commercial evolution

Mar 19 2026

The Beghou Biopharma Review

Closing out 2025: AI's big leap and the search for organizational harmony

Mar 19 2026

The Beghou Biopharma Review

Dealing with dual demands: Tariffs, price caps create competing pressures for pharma marketers

Mar 19 2026